Type 2 Innovation Grant 2020
Opens Feb 1 2020 12:00 AM (CET)
Deadline Jun 15 2020 11:59 PM (CEST)
Description

IMPORTANT – Deadline for application submission has been extended from May 31st to June 15th 11:59 pm CEST

SUBMIT YOUR APPLICATION NOW

Independent research is crucial in discovering new ways to improve human health. That’s why, at Sanofi Genzyme, we are taking an active role in helping research initiatives become a reality by offering research grants to ten innovative projects designed to improve the lives of people with immune-mediated diseases (the “Type 2 Innovation Grant”). 

We have involved IntraMed Communications S.r.l., located at Via Raffaello Bertieri 4, 20146 Milan, Italy (“IntraMed”) to operate and manage the Type 2 Innovation Grant on our behalf.  

If you are interested in participating in the 2020 edition of the Type 2 Innovation Grant, check “The research grant” tab for more information.





Privacy Policy
Rules of Participation
Legal Notice
Cookie Policy
Data Protection Notice 




This site is intended for European Health Care Professionals only.

Sanofi Genzyme and Regeneron are committed to providing resources to advance research in areas of unmet medical need among patients with inflammatory and immunologic diseases. 

©2020 Sanofi and Regeneron Pharmaceuticals, Inc. All rights reserved GZEMEA.AST.19.12.0259. 01/2020

Type 2 Innovation Grant 2020


IMPORTANT – Deadline for application submission has been extended from May 31st to June 15th 11:59 pm CEST

SUBMIT YOUR APPLICATION NOW

Independent research is crucial in discovering new ways to improve human health. That’s why, at Sanofi Genzyme, we are taking an active role in helping research initiatives become a reality by offering research grants to ten innovative projects designed to improve the lives of people with immune-mediated diseases (the “Type 2 Innovation Grant”). 

We have involved IntraMed Communications S.r.l., located at Via Raffaello Bertieri 4, 20146 Milan, Italy (“IntraMed”) to operate and manage the Type 2 Innovation Grant on our behalf.  

If you are interested in participating in the 2020 edition of the Type 2 Innovation Grant, check “The research grant” tab for more information.





Privacy Policy
Rules of Participation
Legal Notice
Cookie Policy
Data Protection Notice 




This site is intended for European Health Care Professionals only.

Sanofi Genzyme and Regeneron are committed to providing resources to advance research in areas of unmet medical need among patients with inflammatory and immunologic diseases. 

©2020 Sanofi and Regeneron Pharmaceuticals, Inc. All rights reserved GZEMEA.AST.19.12.0259. 01/2020

Opens
Feb 1 2020 12:00 AM (CET)
Deadline
Jun 15 2020 11:59 PM (CEST)